Kai Breuer

756 total citations
12 papers, 520 citations indexed

About

Kai Breuer is a scholar working on Pathology and Forensic Medicine, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kai Breuer has authored 12 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 7 papers in Oncology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kai Breuer's work include Lymphoma Diagnosis and Treatment (8 papers), Reproductive Biology and Fertility (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Kai Breuer is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Reproductive Biology and Fertility (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Kai Breuer collaborates with scholars based in Germany, Austria and Italy. Kai Breuer's co-authors include Volker Diehl, Andreas Engert, Michael May, L. Wildt, Beate Klimm, Thorsten Reineke, Karolin Behringer, Andreas Josting, U. Rueffer and Hans Tesch and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Kai Breuer

12 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Breuer Germany 8 258 204 203 201 73 12 520
L. Wickmann Germany 9 202 0.8× 69 0.3× 253 1.2× 43 0.2× 146 2.0× 11 413
Lenka Šmardová Czechia 9 86 0.3× 220 1.1× 256 1.3× 59 0.3× 25 0.3× 28 407
Johannes Rosenbrock Germany 6 118 0.5× 128 0.6× 124 0.6× 85 0.4× 38 0.5× 24 289
G. Schellong Germany 11 448 1.7× 96 0.5× 117 0.6× 33 0.2× 277 3.8× 31 676
A D Leiper United Kingdom 12 375 1.5× 95 0.5× 26 0.1× 62 0.3× 332 4.5× 15 626
L. Casanova Peru 7 58 0.2× 193 0.9× 132 0.7× 16 0.1× 20 0.3× 12 314
Giorgia Annechini Italy 10 66 0.3× 132 0.6× 147 0.7× 49 0.2× 16 0.2× 25 287
Imke Strohscheer Germany 6 43 0.2× 124 0.6× 39 0.2× 52 0.3× 35 0.5× 10 418
Hélène Sudour‐Bonnange France 10 77 0.3× 68 0.3× 15 0.1× 59 0.3× 59 0.8× 35 336
Melissa M. Hudson United States 11 175 0.7× 94 0.5× 116 0.6× 9 0.0× 178 2.4× 20 429

Countries citing papers authored by Kai Breuer

Since Specialization
Citations

This map shows the geographic impact of Kai Breuer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Breuer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Breuer more than expected).

Fields of papers citing papers by Kai Breuer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Breuer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Breuer. The network helps show where Kai Breuer may publish in the future.

Co-authorship network of co-authors of Kai Breuer

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Breuer. A scholar is included among the top collaborators of Kai Breuer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Breuer. Kai Breuer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
3.
Cornely, Oliver A., Harald Seifert, Ullrich Bethe, et al.. (2004). Once-Daily Oral Levofloxacin Monotherapy versus Piperacillin/Tazobactam Three Times a Day: A Randomized Controlled Multicenter Trial in Patients with Febrile Neutropenia. International Journal of Hematology. 79(1). 74–78. 26 indexed citations
4.
Sieniawski, Michal, et al.. (2004). Fertility in male patients with Hodgkin's disease after therapy –results from the German Hodgkin Lymphoma Study Group (GHSG). Journal of Clinical Oncology. 22(14_suppl). 6547–6547. 1 indexed citations
5.
Sieniawski, Michal, Andreas Josting, Kai Breuer, Volker Diehl, & Andreas Engert. (2004). Fertility in Male Patients with Hodgkin’s Disease - Results from the German Hodgkin Lymphoma Study Group (GHSG).. Blood. 104(11). 1315–1315. 1 indexed citations
6.
Proctor, S.J., Jens Ulrich Rueffer, Brian Angus, et al.. (2002). Hodgkin's disease in the elderly: current status and future directions. Annals of Oncology. 13. 133–137. 24 indexed citations
7.
Cornely, Oliver A., Ullrich Bethe, Harald Seifert, et al.. (2001). A randomized monocentric trial in febrile neutropenic patients: ceftriaxone and gentamicin vs cefepime and gentamicin. Annals of Hematology. 81(1). 37–43. 12 indexed citations
8.
Rueffer, U., Kai Breuer, Andreas Josting, et al.. (2001). Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment. Annals of Oncology. 12(9). 1307–1311. 131 indexed citations
9.
Rueffer, U., Andreas Josting, Jeremy Franklin, et al.. (2001). Non-Hodgkin’s Lymphoma After Primary Hodgkin’s Disease in the German Hodgkin’s Lymphoma Study Group: Incidence, Treatment, and Prognosis. Journal of Clinical Oncology. 19(7). 2026–2032. 58 indexed citations
10.
Franklin, Jeremy, U. Paulus, D. Lieberz, et al.. (2000). Is the international prognostic score for advanced stage Hodgkin’s disease applicable to early stage patients?. Annals of Oncology. 11(5). 617–624. 30 indexed citations
11.
Breuer, Kai, et al.. (2000). Langzeittoxizitäten in der Behandlung des Morbus Hodgkin. Medizinische Klinik. 95(7). 378–384. 4 indexed citations
12.
Rueffer, U., M. Sieber, Andreas Josting, et al.. (1999). Prognostic factors for subdiaphragmatic involvement in clinical stage I–II supradiaphragmatic Hodgkin’s disease: A retrospective analysis of the GHSG. Annals of Oncology. 10(11). 1343–1348. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Wickmann Breakdown of academic impact, for papers by Lenka Šmardová Breakdown of academic impact, for papers by Johannes Rosenbrock Breakdown of academic impact, for papers by G. Schellong Breakdown of academic impact, for papers by A D Leiper Breakdown of academic impact, for papers by L. Casanova Breakdown of academic impact, for papers by Giorgia Annechini Breakdown of academic impact, for papers by Imke Strohscheer Breakdown of academic impact, for papers by Hélène Sudour‐Bonnange Breakdown of academic impact, for papers by Melissa M. Hudson
Rankless by CCL
2026